U.S. Bovine Tuberculosis Diagnosis Market Size & Outlook
U.S. bovine tuberculosis diagnosis market, 2018-2030 (US$M)
Related Markets
U.S. bovine tuberculosis diagnosis market highlights
- The U.S. bovine tuberculosis diagnosis market generated a revenue of USD 162.2 million in 2022 and is expected to reach USD 226.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.2% from 2023 to 2030.
- In terms of segment, traditional tests was the largest revenue generating test type in 2022.
- Molecular Diagnostic Tests is the most lucrative test type segment registering the fastest growth during the forecast period.
Bovine tuberculosis diagnosis market data book summary
| Market revenue in 2022 | USD 162.2 million |
| Market revenue in 2030 | USD 226.1 million |
| Growth rate | 4.2% (CAGR from 2022 to 2030) |
| Largest segment | Traditional tests |
| Fastest growing segment | Molecular Diagnostic Tests |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serological Tests, Molecular Diagnostic Tests, Traditional Tests |
| Key market players worldwide | IDEXX Laboratories Inc, Zoetis Inc Class A, Thermo Fisher Scientific Inc, Asure Software Inc, Bio-Rad Laboratories Inc, BioNote, Enfer Medical, IDvet, PBD Biotech |
Other key industry trends
- In terms of revenue, U.S. accounted for 22.2% of the global bovine tuberculosis diagnosis market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. bovine tuberculosis diagnosis market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 226.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bovine Tuberculosis Diagnosis Market Scope
Bovine Tuberculosis Diagnosis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. bovine tuberculosis diagnosis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bovine tuberculosis diagnosis market will help companies and investors design strategic landscapes.
Traditional tests was the largest segment with a revenue share of 60.3% in 2022. Horizon Databook has segmented the U.S. bovine tuberculosis diagnosis market based on serological tests, molecular diagnostic tests, traditional tests covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing awareness of bTB in the U.S. has led to a rise in tuberculin tests, a diagnostic test in animals contributing to the market growth. TB in animals is diagnosed with the help of a successful testing technique of an intradermal injection of tuberculin procured through the State animal health official that produces different varieties of tuberculin Nevertheless.
Since tuberculin test is based on immune response, the animal being tested should not receive other vaccinations, medications, and anthelminthic drugs. Veterinary doctors are also legally in charge of properly conducting and evaluating the tuberculin test results.
Reasons to subscribe to U.S. bovine tuberculosis diagnosis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. bovine tuberculosis diagnosis market databook
-
Our clientele includes a mix of bovine tuberculosis diagnosis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. bovine tuberculosis diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into U.S. bovine tuberculosis diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. bovine tuberculosis diagnosis market size, by test type, 2018-2030 (US$M)
U.S. Bovine Tuberculosis Diagnosis Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
